Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Zynerba Pharmaceuticals NASDAQ ZYNE
$0.0000 0.0000 -%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

-
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-50.43M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.42
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
50.15M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-
Upcoming events Zynerba Pharmaceuticals All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Zynerba Pharmaceuticals

Stock analysis Zynerba Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
- 35.52
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
- 13.63
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
1.31 17.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.31 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-127.53 8.90

Price change Zynerba Pharmaceuticals per year

3.15$ 9.00$
Min Max

Summary analysis Zynerba Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Zynerba Pharmaceuticals

Revenue and net income Zynerba Pharmaceuticals

All parameters
Stock news Zynerba Pharmaceuticals All news
14 August 2023 в 17:25

Zynerba Pharmaceuticals Shares Soar on Harmony Biosciences Deal >ZYNE

14 August 2023 в 17:25

Zynerba Pharmaceuticals Shares Soar on Harmony Biosciences Deal >ZYNE

14 August 2023 в 16:21

Harmony Biosciences to buy Zynerba Pharmaceuticals for up to $200 million

About company Zynerba Pharmaceuticals

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Address:
80 West Lancaster Avenue, Devon, PA, United States, 19333
Company name: Zynerba Pharmaceuticals
Issuer ticker: ZYNE
ISIN: US98986X1090
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2015-08-05
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://zynerba.com

On which stock exchange are Zynerba Pharmaceuticals (ZYNE) stocks traded?

Zynerba Pharmaceuticals (ZYNE) stocks are traded on NASDAQ.

What is the ticker of Zynerba Pharmaceuticals stocks (ZYNE)?

The stock ticker of Zynerba Pharmaceuticals’s stocks or in other words, the code is ZYNE. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Zynerba Pharmaceuticals (ZYNE) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Zynerba Pharmaceuticals (ZYNE) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Zynerba Pharmaceuticals (ZYNE) stocks traded?

Zynerba Pharmaceuticals (ZYNE) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Zynerba Pharmaceuticals (ZYNE) stocks today?

The current price of Zynerba Pharmaceuticals stocks on 02.05.2024 is 0 dollars. per share.

What is the dynamics of Zynerba Pharmaceuticals (ZYNE) stocks from the beginning of the year?

Zynerba Pharmaceuticals (ZYNE) quotes have increased by 0% from the beginning of the year up to 0 dollars. per 1 stocks.

How much did Zynerba Pharmaceuticals (ZYNE) stocks increase in мае 2024?

This month Zynerba Pharmaceuticals (ZYNE) quotes have increased by 0% to 0 dollars. per share.

How much are Zynerba Pharmaceuticals (ZYNE) stocks worth?

Today, on October, 02.05.2024 Zynerba Pharmaceuticals’s (ZYNE) stocks cost 0 dollars..

What is the market capitalization of Zynerba Pharmaceuticals (ZYNE)?

Capitalization is the market value of Zynerba Pharmaceuticals (ZYNE) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 02.05.2024, the market capitalization of Zynerba Pharmaceuticals (ZYNE) is estimated at about 0 dollars.